PMID- 29587799 OWN - NLM STAT- MEDLINE DCOM- 20190613 LR - 20190613 IS - 1479-5876 (Electronic) IS - 1479-5876 (Linking) VI - 16 IP - 1 DP - 2018 Mar 27 TI - HLA alleles modulate EBV viral load in multiple sclerosis. PG - 80 LID - 10.1186/s12967-018-1450-6 [doi] LID - 80 AB - BACKGROUND: The etiopathology of multiple sclerosis (MS) is believed to include genetic and environmental factors. Human leukocyte antigen (HLA) alleles, in particular, are associated with disease susceptibility, whereas Epstein Barr Virus (EBV) infection has long been suspected to play a role in disease pathogenesis. The aim of the present study is to evaluate correlations between HLA alleles and EBV infection in MS. METHODS: HLA alleles, EBV viral load (VL) and serum anti-EBV antibody titers were evaluated in EBV-seropositive MS patients (N = 117) and age- and sex-matched healthy controls (HC; N = 89). RESULTS: Significantly higher DNA viral loads (p = 0.048) and EBNA-1 antibody titer (p = 0.0004) were seen in MS compared to HC. EBV VL was higher in HLA-B*07+ (p = 0.02) and HLA-DRB1*15+ (p = 0.02) MS patients, whereas it was lower in HLA-A*02+ (p = 0.04) subjects. EBV VL was highest in HLA-A*02-/B*07+/DRB1*15+ patients and lowest in HLA-A*A02+/B*07-/DRB1*15- individuals (p < 0.0001). HLA-B*07 resulted the most associated allele to EBV VL after multiple regression analysis considering altogether the three alleles, (p = 0.0001). No differences were observed in anti-EBV antibody titers in relationship with HLA distribution. CONCLUSIONS: Host HLA-B*07 allele influence EBV VL in MS. As HLA-class I molecules present antigens to T lymphocytes and initiate immune response against viruses, these results could support a role for EBV in MS. FAU - Agostini, Simone AU - Agostini S AUID- ORCID: 0000-0002-6214-0645 AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. sagostini@dongnocchi.it. FAU - Mancuso, Roberta AU - Mancuso R AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Guerini, Franca R AU - Guerini FR AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - D'Alfonso, Sandra AU - D'Alfonso S AD - Department of Health Sciences, University of Eastern Piedmont, Novara, Italy. FAU - Agliardi, Cristina AU - Agliardi C AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Hernis, Ambra AU - Hernis A AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Zanzottera, Milena AU - Zanzottera M AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Barizzone, Nadia AU - Barizzone N AD - Department of Health Sciences, University of Eastern Piedmont, Novara, Italy. FAU - Leone, Maurizio A AU - Leone MA AD - IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy. FAU - Caputo, Domenico AU - Caputo D AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Rovaris, Marco AU - Rovaris M AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. FAU - Clerici, Mario AU - Clerici M AD - Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy. AD - Department of Pathophysiology and Transplantation, University of Milan, Via Fratelli Cervi 93, 20090, Milan, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180327 PL - England TA - J Transl Med JT - Journal of translational medicine JID - 101190741 RN - 0 (HLA Antigens) SB - IM MH - Adult MH - *Alleles MH - Case-Control Studies MH - Cytomegalovirus/physiology MH - Female MH - Genotype MH - HLA Antigens/*genetics MH - Herpesvirus 4, Human/*physiology MH - Humans MH - Male MH - Middle Aged MH - Multiple Sclerosis/blood/*genetics/*virology MH - Seroepidemiologic Studies MH - *Viral Load PMC - PMC5870171 OTO - NOTNLM OT - Epstein-Barr virus OT - HLA-A*02 OT - HLA-B*07 OT - HLA-class I alleles OT - Immunogenetics OT - Multiple sclerosis EDAT- 2018/03/29 06:00 MHDA- 2019/06/14 06:00 PMCR- 2018/03/27 CRDT- 2018/03/29 06:00 PHST- 2017/11/17 00:00 [received] PHST- 2018/03/15 00:00 [accepted] PHST- 2018/03/29 06:00 [entrez] PHST- 2018/03/29 06:00 [pubmed] PHST- 2019/06/14 06:00 [medline] PHST- 2018/03/27 00:00 [pmc-release] AID - 10.1186/s12967-018-1450-6 [pii] AID - 1450 [pii] AID - 10.1186/s12967-018-1450-6 [doi] PST - epublish SO - J Transl Med. 2018 Mar 27;16(1):80. doi: 10.1186/s12967-018-1450-6.